<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Evaluation of chronic non-cancer pain in adults
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Evaluation of chronic non-cancer pain in adults
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Evaluation of chronic non-cancer pain in adults
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Tauben, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Brett R Stacey, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Scott Fishman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Marianna Crowley, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 31, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H877128590">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic pain is one of the most common reasons that patients seek medical attention, and affects more than 20 percent of adults and 6 percent of children in the United States alone [
         <a href="#rid1">
          1,2
         </a>
         ]. Chronic pain is defined as that which lasts longer than three to six months, or beyond the duration required for normal tissue healing after an acutely painful event. Chronic pain results from combined biologic, psychologic, and socio-economic factors, and most often requires a multifactorial approach to evaluation and management.
        </p>
        <p>
         This topic will discuss the evaluation of chronic non-cancer pain in adults. Management of chronic non-cancer pain, assessment and management of cancer pain, and the use of opioids for chronic non-cancer pain, are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/126111.html" rel="external">
          "Approach to the management of chronic non-cancer pain in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/126633.html" rel="external">
          "Pharmacologic management of chronic non-cancer pain in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/93598.html" rel="external">
          "Use of opioids in the management of chronic non-cancer pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2795.html" rel="external">
          "Assessment of cancer pain"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Evaluation and management of pain in children is also discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6254.html" rel="external">
          "Pain in children: Approach to pain assessment and overview of management principles"
         </a>
         .)
        </p>
        <p>
         Evaluation and management of specific chronic pain conditions are discussed in multiple separate topics.
        </p>
        <p class="headingAnchor" id="H1959220047">
         <span class="h1">
          EPIDEMIOLOGY AND ECONOMIC IMPACT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 30 percent of patients in developed countries report moderately severe or severe pain that persists longer than six months [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         – A 2023 Centers for Disease Control and Prevention (CDC) analysis of data from the National Health Interview Survey estimated that 20.9 percent of adults (51.6 million) in the United States had chronic pain and 6.9 percent of adults (17.1 million) had high-impact chronic pain with substantial restriction of daily activities [
         <a href="#rid2">
          2
         </a>
         ]. Prevalence of chronic pain and high impact chronic pain was higher among older adults and females. Age adjusted prevalence of chronic pain and high impact chronic pain were significantly higher in American Indian or Alaska Native adults, patients who identified as bisexual, unemployed adults, veterans, and those living in poverty. Adults with disabilities and with poor general health had exceptionally high prevalence of chronic pain (52 and 68 percent, respectively) and high impact chronic pain (32 and 49 percent, respectively).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The prevalence of chronic pain may be more than 40 percent in older adults, with osteoarthritis and low back pain the most common etiologies [
         <a href="#rid4">
          4
         </a>
         ]. The 2016 National Survey of Children's Health reported a 6 percent prevalence of chronic pain among United States children [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Type of pain
         </strong>
         – In a study of results from the National Health Interview Survey for 2019, of those reporting chronic pain the most common locations of were lower extremity pain (hip, knee, and foot, 44.1 percent), and back pain (40.9 percent), followed by upper extremity (31.7 percent, headache [13.6 percent], abdomino-pelvic pain [8.2 percent] and tooth or jaw pain [6.5 percent]) [
         <a href="#rid5">
          5
         </a>
         ]. Neuropathic pain may occur in as many as 10 percent of the general population [
         <a href="#rid6">
          6,7
         </a>
         ]. Common conditions associated with chronic pain are shown in a table  (
         <a class="graphic graphic_table graphicRef126427" href="/z/d/graphic/126427.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Impact
         </strong>
         – Though international prevalence and socio-economic costs of chronic pain reflect significant variability of methods, health systems and gross domestic product, similarly high impact has been reported worldwide, including Europe, Japan, and India, among others [
         <a href="#rid8">
          8-10
         </a>
         ]. The costs of chronic pain in the United States alone are difficult to determine, but in 2010 was estimated at over $560 billion due to direct medical costs, lost productivity, and disability programs (excluding cost of care for children, military personnel, institutionalized adults, and personal caregivers) [
         <a href="#rid3">
          3
         </a>
         ]. In the international Global Burden of Disease Study for 2016, the conditions that caused the largest number of years lost to disability in the United States included low back pain, musculoskeletal disorders, and neck pain [
         <a href="#rid11">
          11
         </a>
         ]. Costs for United States adolescents have been estimated at $19.5 billion [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Chronic pain has a range of psychosocial impacts, and often can lead to discord in the patient's living situation, underemployment, and disability. In addition, if opioids are prescribed for chronic pain, there is a high incidence of misuse, dependence, and opioid use disorder. (See
         <a class="medical medical_review" href="/z/d/html/15236.html" rel="external">
          "Prescription drug misuse: Epidemiology, prevention, identification, and management", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1860007358">
         <span class="h1">
          DEFINITION OF PAIN
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pain is an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. Pain is a complex biopsychosocial phenomenon, as reflected in the 2020 revised definition of pain from the International Association of Pain (IASP) [
         <a href="#rid13">
          13
         </a>
         ] (see
         <a class="local">
          'Chronic pain in context'
         </a>
         below). The IASP definition of pain and associated notes that inform evaluation and management are shown in a table  (
         <a class="graphic graphic_table graphicRef129909" href="/z/d/graphic/129909.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         When an acutely painful condition persists beyond the usually expected 6 to 12 week time course for most healing from disease or injury, it has transitioned from acute to chronic pain. Pathophysiological processes may or may not include active biomedical
         <em>
         </em>
         causes, psychological factors from incident disease and/or from pre-existing disorders of mood and cognition, or social factors [
         <a href="#rid14">
          14,15
         </a>
         ]. Personal or family social issues and economic disruptions, preceding physical or social neglect, sexual or substance abuse, and other adverse or traumatic life events may all affect pain perception [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
         Pain can be classified as nociceptive, neuropathic, and/or nociplastic, and the distinction between these types of pain influences the plan for treatment (see
         <a class="medical medical_review" href="/z/d/html/126111.html" rel="external">
          "Approach to the management of chronic non-cancer pain in adults", section on 'General approach'
         </a>
         and
         <a class="local">
          'Pathophysiology of pain'
         </a>
         below). Definitions of the types of pain and related terms are shown in a table  (
         <a class="graphic graphic_table graphicRef126428" href="/z/d/graphic/126428.html" rel="external">
          table 3
         </a>
         ).
        </p>
        <p>
         The United Kingdom 2021 National Institute for Health and Care Excellence (NICE) guidelines for assessment and management of chronic pain propose differentiating primary from secondary chronic pain conditions [
         <a href="#rid17">
          17
         </a>
         ]. This classification was in response to new International Classification of Diseases (ICD)-11 coding that allowed for fibromyalgia, complex regional pain syndrome, and non-specific low back pain to be specified as diseases in their own right [
         <a href="#rid18">
          18,19
         </a>
         ]. Such classification relies upon accurate diagnosis of an underlying condition, versus finding that the impact of pain is disproportional to an observed injury or disease, though the guideline notes that primary and secondary pain can coexist. We do not use this classification, which risks a false dichotomy between pain that is real versus unreal as a result of a psychosocial disorder. We view chronic pain as a disease unto itself, regardless of how it starts.
        </p>
        <p class="headingAnchor" id="H2501150571">
         <span class="h1">
          PATHOPHYSIOLOGY OF PAIN
         </span>
         <span class="headingEndMark">
          —
         </span>
         The physiology of pain is complex, and an in-depth discussion is beyond the scope of this topic. Briefly, painful stimuli arising in the periphery are received by specialized nociceptors that selectively respond to a range of aversive stimuli (eg, temperature, pressure, pH). Peripheral nociceptive input is transmitted through the dorsal horn of the spinal column where interneurons modulate and project signals to a distributed range of central nervous system (CNS) structures, including brainstem, limbic, subcortical, associative, and somatosensory brain regions. Pain is a dynamically linked spatiotemporal event, experienced through multi-segmental [
         <a href="#rid20">
          20
         </a>
         ] descending inhibitory and facilitatory signals arising from both the periphery and from the brain  (
         <a class="graphic graphic_figure graphicRef127212" href="/z/d/graphic/127212.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
         Transmission of pain and modulatory signaling involves multiple dynamic and widely distributed bidirectional pathways of excitatory and inhibitory receptors and neurotransmitters, which are targets for the treatment of pain. Drug treatment for chronic pain can target several sites, including neuroreceptors (eg, opioid receptors), ion channels (eg, calcium and sodium channels), and neurotransmitters (eg, norepinephrine and serotonin). The major analgesic targets and related drugs are shown in a table  (
         <a class="graphic graphic_table graphicRef126429" href="/z/d/graphic/126429.html" rel="external">
          table 4
         </a>
         ). Non-drug treatments targeting mostly peripherally-acting mechanisms include acupuncture, dry needling, manipulation, and transcutaneous and peripheral nerve stimulation, among others. Non-drug treatments that are mostly centrally-acting include cognitive-behavioral therapies, sleep hygiene, and spinal neurostimulation devices, among others. Non-pharmacologic treatments that target both peripheral and central pain processes include exercise, guided motor imagery, and yoga, among others.
        </p>
        <p class="headingAnchor" id="H1087120702">
         <span class="h2">
          Nociceptive pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nociceptive pain is caused by stimuli that threaten or result from bodily tissue damage. Nociceptive pain is expected after surgical and other acute traumatic injury, and is associated with a range of musculoskeletal and visceral conditions that involve inflammatory, ischemic, infectious, or mechanical/compressive injury. Chronic pain may occur with persisting nociceptive signaling from medical disorders that persist despite aggressive treatment for underlying cause, such as with degenerative, inflammatory, and neoplastic diseases.
        </p>
        <p class="headingAnchor" id="H2621259520">
         <span class="h2">
          Neuropathic pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuropathic pain results from a maladaptive response to damage or disease of the somatosensory nervous system, and consists of a central and/or peripheral disorder of pain modulation [
         <a href="#rid6">
          6
         </a>
         ]. Often, damage to the nervous system results in only a loss of function (eg, numbness, weakness), but with neuropathic pain there is a gain of function (pain). Neuropathic pain can occur in the absence of active noxious stimulus, or as an exaggerated response to minor or moderate nociceptive stimulus [
         <a href="#rid21">
          21,22
         </a>
         ].
        </p>
        <p>
         Causes of neuropathic pain are multiple and varied, and include peripheral (eg, painful diabetic neuropathy, postherpetic neuralgia, nerve trauma, autoimmune disorders) and CNS sites of initial injury or disease (eg, stroke or spinal cord injury, multiple sclerosis, trigeminal neuralgia); but the sustaining physiology may very much involve both the peripheral nervous system and the CNS, as described for both painful diabetic neuropathy and phantom limb pain [
         <a href="#rid3">
          3,23-25
         </a>
         ]. Often, the etiology is unknown. The pathophysiology and manifestations of neuropathic pain are highly variable among individual patients and etiologies.
        </p>
        <p>
         Neuropathic pain has traditionally been subdivided by the disease or anatomic location of the inciting injury. However, emerging evidence suggests that combining the pain description (burning, intermittent, constant) and physical examination (abnormal pain due to a stimulus that does not normally provoke pain [allodynia], increased pain from a stimulus that normally provokes pain [hyperalgesia], or loss of sensation) may better help categorize patients (known as "phenotyping") so that more specific therapies can be offered [
         <a href="#rid26">
          26,27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2277897158">
         <span class="h2">
          Nociplastic pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term "nociplastic," pain was coined to recognize that many patients have pain that is not fully described by tissue injury (nociceptive pain) or nerve injury or disease (neuropathic pain) [
         <a href="#rid28">
          28
         </a>
         ]. Nociplastic pain is defined by the International Association for the Study of Pain (IASP) as pain that results from altered nociception, without evidence of actual or threatened tissue damage that causes activation of peripheral nociceptors, and without evidence for disease or a lesion causing the pain [
         <a href="#rid28">
          28
         </a>
         ]. This change was made in response to advances in many fields of pain research and efforts in ICD-11 to qualify a number of better understood chronic pain conditions as diseases in their own right [
         <a href="#rid18">
          18
         </a>
         ]. The term "nociplastic" pain may not yet be routinely used clinically; it conveys similar concepts as terms such as "central sensitization," and "centralization." Nociplastic pain can augment nociceptive pain and/or neuropathic pain and may be accompanied by more broad hypersensitivity to other sensory stimuli (sound, light, odors).
        </p>
        <p>
         Altered pain sensory processing and impaired central pain modulation appear to play a prominent role in many chronic pain conditions such as fibromyalgia [
         <a href="#rid29">
          29
         </a>
         ], a number of rheumatic and musculoskeletal disorders (eg, osteoarthritis [
         <a href="#rid30">
          30,31
         </a>
         ]), common chronic visceral pain conditions (eg, irritable bowel syndrome [
         <a href="#rid32">
          32
         </a>
         ], chronic pancreatitis [
         <a href="#rid33">
          33
         </a>
         ], chronic pelvic pain [
         <a href="#rid34">
          34
         </a>
         ], interstitial cystitis [
         <a href="#rid35">
          35
         </a>
         ], and sickle cell disease [
         <a href="#rid36">
          36
         </a>
         ]). These co-occurring conditions often present clinically with findings of widespread pain, hyperalgesia and allodynia  (
         <a class="graphic graphic_table graphicRef126430" href="/z/d/graphic/126430.html" rel="external">
          table 5
         </a>
         ) [
         <a href="#rid37">
          37
         </a>
         ]. These conditions are characterized by the neurophysiologic phenomenon of "central sensitization," or "nociplasticity," which may also play a role in the transformation of acute pain into chronic pain. When nociplastic pain is present, somatic or bodily processes often will play an important role in ongoing nociceptive (eg, in osteoarthritic) or neuropathic (eg, in diabetes) pain, and their combined management contributes to the level, extent, or impact of the pain.
        </p>
        <p>
         Pathophysiologic changes in brain function have been demonstrated with functional magnetic resonance imaging (fMRI) and other imaging techniques [
         <a href="#rid38">
          38,39
         </a>
         ]. Mechanisms of dysfunctional neuroplastic transformation are incompletely understood and are areas of active research [
         <a href="#rid40">
          40-42
         </a>
         ]. Mechanisms, diagnosis, and the approach to treatment of centralized pain are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/118590.html" rel="external">
          "Overview of chronic widespread (centralized) pain in the rheumatic diseases", section on 'Definitions and pain mechanisms'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1259106099">
         <span class="h1">
          RISK FACTORS FOR DEVELOPING CHRONIC PAIN
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of patient factors increase the risk of developing chronic pain, including genetics, patient fears and expectations, prior poor pain-related treatment outcomes, psychiatric and behavioral co-occurring conditions, adverse social issues, older age, and long-term opioid use. Acute pain may transition to chronic pain for a variety of reasons, including the nature of disease or injury, and if important psychosocial factors are left unaddressed in the months following onset of painful injuries and diseases. Identification and treatment of risk factors that contribute to pain chronification may reduce the likelihood of patients transitioning from acute pain to chronic pain  (
         <a class="graphic graphic_table graphicRef126435" href="/z/d/graphic/126435.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="local">
          'Patient evaluation'
         </a>
         below.)
        </p>
        <p>
         Some injuries and surgical procedures are associated with a high risk of persistent pain (eg, hernia repair, breast surgery), and poorly treated postoperative pain may increase the risk of chronic pain. As an example, properly managed acute pain may prevent persistent pain after total knee arthroplasty (TKA) [
         <a href="#rid43">
          43
         </a>
         ], and may reduce the long-term use of opioids after TKA [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         Family history of chronic pain may increase the risks of some medical conditions associated with chronic pain (eg, headaches, fibromyalgia, inflammatory diseases) and/or behavioral health conditions (eg, depression, anxiety, posttraumatic stress disorder [PTSD] [
         <a href="#rid45">
          45,46
         </a>
         ], substance abuse disorders [
         <a href="#rid47">
          47
         </a>
         ]).
        </p>
        <p>
         Several reviews of early and emerging literature have reported a heterogeneous spectrum of chronic pain symptoms following COVID-19 infections [
         <a href="#rid48">
          48-50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H277771116">
         <span class="h1">
          CHRONIC PAIN IN CONTEXT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pain is experienced in developmental, social, and emotional contexts [
         <a href="#rid51">
          51
         </a>
         ]. Whether pain is acute or chronic, it is a biopsychosocial phenomenon [
         <a href="#rid52">
          52
         </a>
         ], and when pain has become chronic its management typically requires multidimensional structured assessment and treatment  (
         <a class="graphic graphic_table graphicRef129909" href="/z/d/graphic/129909.html" rel="external">
          table 2
         </a>
         ). Negative emotions and expectations, such as fear and catastrophizing about impact of pain on the patient's job, parenting, loss of income and other life roles, can amplify the perception of pain. Fears of relapse when pain occurs in cancer survivors may heighten pain severity [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         Socioeconomic status, geography, access to health care, availability of exercise, and culture all impact the pain experience and treatment options. Chronic pain should be evaluated understanding these issues, as well as the patient's age and developmental stage of life, ranging from childhood through adulthood and into older age. Evaluation and management of pain must consider the sensory, cognitive, and emotional factors that change over the lifespan, the roles of caregivers, and should use developmentally appropriate assessment measures [
         <a href="#rid54">
          54-56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6254.html" rel="external">
          "Pain in children: Approach to pain assessment and overview of management principles"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16525.html" rel="external">
          "Treatment of chronic non-cancer pain in older adults"
         </a>
         .)
        </p>
        <p>
         Other aspects of the patient's life may also affect treatment decisions. For instance, pregnancy is often associated with low back pain, and pregnancy can complicate the choice of medication treatment options for chronic pain, particularly the use of opioids [
         <a href="#rid57">
          57,58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4790.html" rel="external">
          "Opioid use disorder: Overview of treatment during pregnancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/87238.html" rel="external">
          "Opioid use disorder: Pharmacotherapy with methadone and buprenorphine during pregnancy"
         </a>
         .)
        </p>
        <p>
         A patient-clinician interaction that creates a positive and healing therapeutic relationship can be expected to improve treatment compliance, engagement, and outcome response [
         <a href="#rid59">
          59
         </a>
         ]. The psychophysiologic placebo response [
         <a href="#rid60">
          60
         </a>
         ] can be effective therapy for patients with chronic pain, as it is for much of medicine, particularly if the patient and clinician develop a long-term relationship in an outpatient setting (eg, a primary care clinical setting) as opposed to an urgent care facility or emergency department.
        </p>
        <p class="headingAnchor" id="H1075712168">
         <span class="h1">
          PATIENT EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Evaluation of the patient with chronic pain requires a systematic search for biomedical causes and contributing factors, psychologic evaluation, assessment of physical capability (including job and/or life role) and sleep function, and determination of social factors that may increase pain severity and worsen clinical outcomes. Assessment should include comprehensive medical assessment, and pain-focused history and physical examination  (
         <a class="graphic graphic_table graphicRef126456" href="/z/d/graphic/126456.html" rel="external">
          table 7
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H1437640603">
         <span class="h2">
          Past medical and surgical history
         </span>
         <span class="headingEndMark">
          —
         </span>
         The medical history and review of systems can help determine the etiology of chronic pain (eg, diabetes, history of cancer, rheumatic diseases)  (
         <a class="graphic graphic_table graphicRef126427" href="/z/d/graphic/126427.html" rel="external">
          table 1
         </a>
         ) and may reveal conditions that affect the choice of therapy, eg, avoidance of sedatives and opioids in the setting of sleep disordered breathing [
         <a href="#rid61">
          61
         </a>
         ] or chronic pulmonary disease [
         <a href="#rid62">
          62
         </a>
         ], considerations of drug clearance and metabolism in the setting of renal or liver dysfunction, or potential risk of antidepressants in patients with cardiovascular disease [
         <a href="#rid63">
          63
         </a>
         ]).
        </p>
        <p class="headingAnchor" id="H3860907015">
         <span class="h2">
          Review of systems
         </span>
         <span class="headingEndMark">
          —
         </span>
         A "pan-positive," review of systems may suggest conditions associated with nociplastic sensory hypersensitivity [
         <a href="#rid64">
          64
         </a>
         ] (ie, central sensitization, discussed above) and may support a syndromic pain diagnosis, such as chronic fatigue, headache, visceral pain, or widespread conditions such as fibromyalgia. (See
         <a class="medical medical_review" href="/z/d/html/2740.html" rel="external">
          "Clinical features and diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5624.html" rel="external">
          "Clinical manifestations and diagnosis of fibromyalgia in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1464620355">
         <span class="h2">
          Social and family history
         </span>
         <span class="headingEndMark">
          —
         </span>
         The patient's social history may reveal issues that affect the development and treatment of chronic pain, including early childhood exposures to traumatic events and/or threatening community environments (and so risk for posttraumatic stress disorder [PTSD]) [
         <a href="#rid65">
          65
         </a>
         ]; marital/partner stability; educational attainment and employment history; past and current family construct; and the use of tobacco, alcohol and other at-risk drugs for poor pain treatment outcomes, including long-term opioid use [
         <a href="#rid66">
          66
         </a>
         ]. (See
         <a class="local">
          'Risk screening'
         </a>
         below.)
        </p>
        <p>
         Social issues may increase the risk of chronic pain and the risk of long-term opioid use [
         <a href="#rid66">
          66
         </a>
         ], and affect the response to therapy. Stability of the patient's living situation, employment history or disability, level of education, and use of tobacco or alcohol should all be assessed during evaluation for chronic pain. Childcare or other caregiver requirements, transportation barriers, or concerns about missed time at work may reduce access to care options.
        </p>
        <p>
         Where services are available, patients with social challenges may be referred to case workers or social services for assistance. Collaborative care models that include a wide range of health professionals and care coordinators can also increase treatment engagement, align expectations, and so improve outcomes [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
         Family history of chronic pain may also identify predisposition to pain-associated medical conditions (eg, headaches, fibromyalgia, inflammatory diseases) and/or behavioral health conditions (eg, depression, substance abuse disorders).
        </p>
        <p class="headingAnchor" id="H4218224901">
         <span class="h2">
          Psychiatric comorbidity
         </span>
         <span class="headingEndMark">
          —
         </span>
         We routinely screen patients with chronic pain for psychiatric and behavioral problems (see
         <a class="local">
          'Pain severity and impact'
         </a>
         below) since many patients presenting with high impact chronic pain also have histories of primary psychiatric comorbidity [
         <a href="#rid68">
          68
         </a>
         ]. Depression, anxiety, PTSD [
         <a href="#rid65">
          65
         </a>
         ], substance abuse, and other psychiatric disorders can present obstacles to diagnosing and treating many pain syndromes [
         <a href="#rid69">
          69
         </a>
         ]. Patients with longstanding or complex pain problems should be treated with a multidisciplinary approach that includes an evaluation by and close collaboration with a behavioral and/or medical health professional (based on indications for pharmacologic support) who can diagnose and treat the psychologic/psychiatric aspects of the condition  (
         <a class="graphic graphic_table graphicRef126443" href="/z/d/graphic/126443.html" rel="external">
          table 8
         </a>
         ). (See
         <a class="local">
          'Pain severity and impact'
         </a>
         below.)
        </p>
        <p>
         Symptoms of concurrent psychiatric problems can worsen chronic pain. Sleep disturbance, loss of appetite, lack of energy, and diminished physical activity contribute to an increasingly debilitated state and amplify the patient's pain and hopelessness. Chronic pain can worsen depression and anxiety, and interfere with successful antidepressant treatment [
         <a href="#rid70">
          70
         </a>
         ]. Patients with chronic pain commonly describe a lack of pleasure, catastrophic thinking, reduced motivation, hopelessness, social isolation, fatigue, and an absence of control in their lives. Chronic pain is associated with a higher risk of suicide, suicidal ideation, and suicide attempts [
         <a href="#rid71">
          71,72
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1708.html" rel="external">
          "Suicidal ideation and behavior in adults", section on 'Other'
         </a>
         .)
        </p>
        <p>
         While appropriate treatment of depression may improve pain, especially in somatically expressive instances of depression, we do not conflate treating depression with treating pain. Managing mood is an essential aspect of care for many patients with chronic pain but rarely represents the only treatment. In patients for whom the symptoms of depression are a complicating feature and sometimes natural sequel to life with chronic pain, antidepressant treatment can relieve the distress and emotional intensity with which physical pain is experienced [
         <a href="#rid73">
          73
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/126633.html" rel="external">
          "Pharmacologic management of chronic non-cancer pain in adults", section on 'Antidepressants'
         </a>
         .)
        </p>
        <p>
         Chronic pain disorders with identifiable pathophysiologic causes overlap with many common conditions that are attributed to "functional" causes, such as irritable bowel syndrome, and so can be mistakenly treated as simply psychiatric or behavioral disorders  (
         <a class="graphic graphic_table graphicRef126430" href="/z/d/graphic/126430.html" rel="external">
          table 5
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H1045258245">
         <span class="h2">
          Pain assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pain assessment informs the choice of therapy and should be used to monitor the effect of therapy. Every effort should be made to make a specific pain diagnosis or, when several different pain conditions are present, several diagnoses, to avoid the imprecise and non-specific "chronic pain" label. Pain assessment can be confounded by beliefs, attitudes, and implicit biases of evaluating clinicians, especially when clear evidence of tissue injury may no longer be present [
         <a href="#rid74">
          74
         </a>
         ]. For patients with a pre-existing diagnosis of chronic pain, a thoughtful effort should be made to consider whether a new condition may be the cause for a new pain complaint, especially when a significant change in the characteristics or pattern of pain are present.
        </p>
        <p class="headingAnchor" id="H2331253810">
         <span class="h3">
          Pain history
         </span>
         <span class="headingEndMark">
          —
         </span>
         We initiate assessment of the history of the patient's pain with the questions represented by the acronym "OLDCARTS," which are used to broadly characterize the pain and are shown in a table  (
         <a class="graphic graphic_table graphicRef126444" href="/z/d/graphic/126444.html" rel="external">
          table 9
         </a>
         ). Since patients often present with more than one pain complaint, each pain problem that is medically and potentially diagnostically distinct (eg, neck pain and right knee pain) should be characterized as thoroughly as the clinical situation warrants. Rather than focusing on the currently predominant pain issue, looking at all the areas of pain often results in a clearer understanding of the patient and appropriate treatment options.
        </p>
        <p>
         Importantly, treatment notes and records should be reviewed, including previous beneficial and failed therapies (ie, drug doses and duration, behavioral health treatments, physical therapy, interventional procedures, prior surgeries). The authors have often found that many prior treatments are called "ineffective" due to inadequate dose, duration, or timing; or "failed" due to poor communication of rationale and value (eg, a referral for psychologist or physical therapist) or side effects that could have potentially been avoided (eg, slower titration or alternative same category drug). (See
         <a class="medical medical_review" href="/z/d/html/2814.html" rel="external">
          "Cancer pain management with opioids: Optimizing analgesia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/93598.html" rel="external">
          "Use of opioids in the management of chronic non-cancer pain"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1324388140">
         <span class="h3">
          Location of pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         We ask patients to complete a body diagram map as a key initial step of pain assessment and continue its regular use during routine follow-up  (
         <a class="graphic graphic_figure graphicRef126454" href="/z/d/graphic/126454.html" rel="external">
          figure 2
         </a>
         ). The body pain diagram delineates the location and extent of pain and distinguishes between focal or radiating pain and widespread or total body pain. Patient descriptions of pain location may not fit with clinicians' use of medical terms (eg, hip pain, sciatica) and the pain diagram can help clarify. We ask patients to indicate
         <strong>
          all
         </strong>
         of their painful areas on the body diagram, which may reveal a less localized process. Widespread pain may result from a systemic inflammatory disorder, such polymyalgia rheumatica, or suggests a hypersensitivity disorder, such as fibromyalgia. (See
         <a class="local">
          'Nociplastic pain'
         </a>
         above.)
        </p>
        <p>
         New areas of pain on the body diagram can be compared easily with previously described symptomatic sites. We find that the body diagram can facilitate treatment planning and subsequent assessment. Body diagrams are available as an interactive computerized format, or can be completed on paper.
        </p>
        <p class="headingAnchor" id="H3318282325">
         <span class="h3">
          Pain characteristics
         </span>
         <span class="headingEndMark">
          —
         </span>
         The choice of an appropriate initial therapeutic strategy is dependent upon an accurate evaluation of the cause of the pain and the type of chronic pain syndrome. In particular, neuropathic pain should be distinguished from nociceptive pain, and either or both can be associated with nociplastic pain. Patient reported pain descriptors most characteristic of neuropathic pain include tingling or pins and needles, burning, and shooting or electric shock. While these characteristics are included in most of the published screening tools for neuropathic pain [
         <a href="#rid75">
          75-78
         </a>
         ], an accurate history and physical examination remains the clinical standard for identifying the presence of neuropathic pain. (See
         <a class="local">
          'Physical examination'
         </a>
         below.)
        </p>
        <p>
         A proper multidimensional evaluation includes a complete inventory of recent and active patient reported complaints, especially for patients with widespread nociplastic pain or pain of uncertain cause. For these patients the authors consider using the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.physiotutors.com%2Fquestionnaires%2Fcentral-sensitization-inventory-csi%2F&amp;token=x44j3owCE8bgzsF65rcOxODCiX%2FFdmlZ6KwyjDZXUw%2BY7zahvcH47iIKwCI93h3G0343EoXJ52IGKNhgiHCU93n8ft6gADJHBMV4DggL1W4%3D&amp;TOPIC_ID=116196" target="_blank">
          Central Sensitization Inventory
         </a>
         [
         <a href="#rid79">
          79-82
         </a>
         ]. However, if the patient has widespread pain and a clinical history of sensitization, an additional tool may not change the approach to the patient. The Central Sensitization Inventory identifies both the presence and severity of central sensitization and can be used in acute, chronic, and perioperative patients, including adolescents [
         <a href="#rid79">
          79,80,82
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3444790027">
         <span class="h3">
          Pain severity and impact
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic pain and the efficacy of therapy should be assessed in terms of function and quality of life, in addition to pain intensity. Numeric pain rating scales are not adequate sole metrics for the severity of pain [
         <a href="#rid83">
          83
         </a>
         ]. We agree with practice guidelines for the treatment of chronic pain, including the 2016 Centers for Disease Control and Prevention (CDC) guideline for prescribing opioids for chronic pain, which recommend that pain and pain therapy should be assessed with a multidimensional set of measures, including patient reported outcomes. This approach is consistent with the multidimensional experience of chronic pain [
         <a href="#rid58">
          58,84
         </a>
         ].
        </p>
        <p>
         For multidimensional assessment of pain severity and impact in the primary care setting, we ask patients to complete the following questionnaires for initial evaluation and at each follow-up visit. This assessment consists of the body diagram and approximately 10 questions that can be completed quickly on paper or using a computerized record  (
         <a class="graphic graphic_table graphicRef126456" href="/z/d/graphic/126456.html" rel="external">
          table 7
         </a>
         ). For more challenging patients, especially those with high impact or widespread pain, we recommend adding the 4 item Pain Catastrophizing Scale (PCS-4 item).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          PEG score
         </strong>
         – The validated
         <strong>
          P
         </strong>
         ain intensity, pain interference with
         <strong>
          E
         </strong>
         njoyment of life and
         <strong>
          G
         </strong>
         eneral activity (PEG) score includes three questions that are scored on a scale from 0 to 10 [
         <a href="#rid85">
          85
         </a>
         ]. The PEG tool allows for more than a single item pain intensity score, since improvement in baseline of enjoyment and quality of life and general function are key goals of chronic pain treatment. Each is scored on a 0 to 10 out of 10 numeric rating, and either cumulatively added or individually scored, and subsequently tracked for improvement at each pain-related visit. Extremely elevated individual or total PEG scores suggests poor pain care status. Use of the PEG tool allows the clinician to follow specific treatments directed toward improving enjoyment of life and general function (eg, identifying what defines enjoyment of life for that individual, identifying how specific performance goals can be achieved). These domains are assessed and reassessed longitudinally over time relative to baseline; this report is reformatted to be shared with the patient at each visit to support engagement  (
         <a class="graphic graphic_form graphicRef126457" href="/z/d/graphic/126457.html" rel="external">
          form 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mental health
         </strong>
         –
         <strong>
         </strong>
         These pain evaluation instruments aim for more reliable diagnosis and precise targeting of mental health conditions and determining the type of behavioral health specialty provider for referral when indicated.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The validated Four-item Patient Health Questionnaire (PHQ-4)  (
         <a class="graphic graphic_table graphicRef100637" href="/z/d/graphic/100637.html" rel="external">
          table 10
         </a>
         ) for anxiety and depression includes two items from the General Anxiety Disorder (GAD-7) score and two items from the Personal Health Questionnaire (PHQ-9) depression measure [
         <a href="#rid86">
          86
         </a>
         ]. When PHQ-4 score is greater than 5, more detailed screeners are recommended, and we recommend the full PHQ-9  (
         <a class="graphic graphic_table graphicRef59307" href="/z/d/graphic/59307.html" rel="external">
          table 11
         </a>
         ), the full GAD-7 (
         <a class="calc calc_professional" href="/z/d/html/117273.html" rel="external">
          calculator 1
         </a>
         ), and the Primary Care 5-question PTSD screener  (
         <a class="graphic graphic_table graphicRef115475" href="/z/d/graphic/115475.html" rel="external">
          table 12
         </a>
         ) [
         <a href="#rid87">
          87,88
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We do not routinely screen for pain amplification, which is sometimes referred to as catastrophizing, and instead screen selectively. We avoid using the term "catastrophizing," as it is sometimes viewed as pejorative. The Pain Catastrophizing Scale (PCS) is a widely used psychosocial instrument for patients across a range of chronic pain diagnoses, including complex regional pain syndrome, fibromyalgia, chronic migraines, post-surgical pain and chronic pelvic pain. Both the validated 13 question version and a more recently developed 4 item scale (PCS-4 Item) can better predict poor functional treatment outcomes such as higher pain intensity, longer hospitalization, postoperative pain chronification, functional disability, patient dissatisfaction, and opioid misuse [
         <a href="#rid89">
          89,90
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          The Defense and Veterans Pain Rating Scale (DVPRS)
         </strong>
         – This is a visually appealing and easy to administer five-item chronic pain assessment tool, with 0 to 10 out of 10 ratings for pain intensity and pain interference with activity, sleep, mood, and stress  (
         <a class="graphic graphic_form graphicRef126451" href="/z/d/graphic/126451.html" rel="external">
          form 2
         </a>
         ). DVPRS has been validated in United States military medicine primary care health setting [
         <a href="#rid91">
          91
         </a>
         ], but it is not yet generalizable for other primary care settings.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sleep
         </strong>
         – We evaluate all chronic pain patients for problems with sleep. At each visit, the authors ask patients to rate 0 to 10 out of 10 how much pain interferes with falling sleep, and whether pain interferes with staying asleep.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Management of pain is the primary method for improving sleep in patients with chronic pain, while sleeplessness increases pain intensity and frequency [
         <a href="#rid92">
          92
         </a>
         ]. In our experience, treatment of insomnia often improves patient reported function, quality of life, and satisfaction with treatment. Thus, improving sleep quality and duration is an important goal for optimal pain relief. Difficulty with initiating sleep often responds well to sleep hygiene self-management techniques, and when necessary, to cognitive-behavioral therapy for insomnia [
         <a href="#rid93">
          93
         </a>
         ]. Difficulties with sleep maintenance may be a symptom of depression anxiety, and/or PTSD, and specialty referral may be needed. Treatment of insomnia is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/97867.html" rel="external">
          "Overview of the treatment of insomnia in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We screen patients for obstructive sleep apnea (OSA) with the STOP-Bang questionnaire  (
         <a class="graphic graphic_table graphicRef87572" href="/z/d/graphic/87572.html" rel="external">
          table 13
         </a>
         ). OSA is common and important to identify in patients with chronic pain, especially since patients commonly report fatigue during the review of systems, and many patients are taking sedatives and/or opioids. Patients who are deconditioned due to pain may be overweight or obese, and therefore at increased risk of OSA. (See
         <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">
          "Clinical presentation and diagnosis of obstructive sleep apnea in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1971317610">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         A comprehensive physical examination should be performed for all patients with chronic pain, including during pain specialist consultation, to identify areas for treatment and potentially relevant anatomic and physiologic abnormalities. An examination focused on the painful site may be appropriate to evaluate a well-localized pain in a patient without pre-existing chronic pain or comorbidities. Our typical practice is a screening general musculoskeletal examination of all regions (gait, spine range of motion, major joint range of motion), a neurologic examination including assessment of sensation to more than one modality (pinprick, light touch, vibration), and a more focal area of painful areas. Examples of findings that may be helpful include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A skin rash or nail bed stippling may support a diagnosis of an inflammatory arthritis or myopathy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Widespread pain hypersensitivity to palpation may suggest a more complex centralized pain process.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Presence of a neurologic deficit (sensory loss, weakness, reflex change) and reports of abnormal sensation, motor or reflex deficits, or pain in response to light touch (allodynia), or pinprick (hyperalgesia) in the area of pain supports a neuropathic pain diagnosis. A higher degree of pain reported to ordinarily a low-level applied pressure may support a diagnosis of fibromyalgia, central sensitization, or other widespread pain disorder  (
         <a class="graphic graphic_table graphicRef126428" href="/z/d/graphic/126428.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Nociplastic pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyperreflexia may indicate spinal cord myelopathy (eg, compression, syrinx, or multiple sclerosis) in a patient reporting focal muscle tenderness in the neck or numbness in a distant site, or drug withdrawal, among other possible causes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Altered gait or range of motion may point to functional limitations that can be addressed with physical rehabilitation.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2685552370">
         <span class="h2">
          Diagnostic studies for the evaluation of pain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Appropriate laboratory, imaging, and other testing can be helpful to evaluate or follow certain painful conditions.
        </p>
        <p class="headingAnchor" id="H1665669131">
         <span class="h3">
          Imaging studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging with a plain radiograph is useful if a specific site of bone or joint pain related to an injury or disease is not clearly diagnosed by history and physical exam, or if surgery or an interventional procedure such as a joint injection is contemplated. However, routine radiographs without a specific diagnostic or therapeutic target are frequently low yield. Radiograph findings may not correlate with pain severity due to mechanisms of sensitization, and treatment for a sensory hypersensitivity condition may be more effective than targeting peripheral causes [
         <a href="#rid94">
          94,95
         </a>
         ].
        </p>
        <p>
         It is well recognized that magnetic resonance imaging (MRI) of the spine [
         <a href="#rid96">
          96
         </a>
         ] may identify pathology of uncertain significance, without clear correlation with clinical severity or outcomes. It is important to communicate to the patient that abnormal, "degenerative" MRI findings may be quite normal for the patient's age, to prevent worrisome notions and catastrophizing thoughts of danger and risk that worsen rather than improve pain management. Many radiology experts and imaging centers have added interpretative comments to normalize common degenerative findings as "to be expected" [
         <a href="#rid97">
          97-99
         </a>
         ]. Indications for imaging for back pain and the limitations of imaging are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7782.html" rel="external">
          "Evaluation of low back pain in adults", section on 'Indications for imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7782.html" rel="external">
          "Evaluation of low back pain in adults", section on 'Limited utility of imaging'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3027276397">
         <span class="h3">
          Diagnostic nerve blocks
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic procedures, such as selective peripheral nerve anesthetic, can be used to localize a potential cause at a specific painful site, but a short-acting anesthetic block does not typically provide durable pain relief. A local anesthetic block may increase the patient's tolerated range of motion, and thereby facilitate physical therapy. Pain relief from spinal (axial) nerve blocks (eg, medial branch block for facet pain) may indicate a role for a more durable focally destructive sensory nerve radiofrequency ablation procedure. (See
         <a class="medical medical_review" href="/z/d/html/126111.html" rel="external">
          "Approach to the management of chronic non-cancer pain in adults", section on 'Interventional therapy for chronic pain'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14248.html" rel="external">
          "Interventional therapies for chronic pain"
         </a>
         .)
        </p>
        <p>
         Selective nerve blocks should be avoided for patients with widespread pain and/or high psychosocial distress measures, as assessed by PEG or PHQ-4 scores (see
         <a class="local">
          'Pain severity and impact'
         </a>
         above). For these patients, a selective nerve block will be low yield and may result in clinical worsening because of unmet expectations, increased frustration with care, delay in effective therapies, and unnecessary cost.
        </p>
        <p class="headingAnchor" id="H3520102125">
         <span class="h3">
          Evaluation of neurologic deficits
         </span>
         <span class="headingEndMark">
          —
         </span>
         Electrodiagnostic testing (eg, nerve conduction studies) may be useful to define a compressive focal neuropathy, such as one derived from a spinal root (ie, radiculopathy), a peripheral nerve (eg, carpal tunnel), or to determine if neuropathic pain is caused by a sensory mono- or polyneuropathy (eg, diabetic neuropathy). Before ordering such a study, which can be painful, consider whether the study will contribute meaningfully to the clinical diagnosis and treatment plan. Consultation with a neurologist or rehabilitation medicine specialist may help determine the need for electrodiagnostic testing or other evaluation. In our specialty clinic we often detect a peripheral neuropathy on examination and make the diagnosis of diabetes, pre-diabetes, or vitamin deficiencies with routine clinical laboratory testing while avoiding electrodiagnostic testing. (See
         <a class="medical medical_review" href="/z/d/html/5284.html" rel="external">
          "Overview of polyneuropathy", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H625281269">
         <span class="h2">
          Risk screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         When prescribing opioids long-term, the 2017 United States CDC guideline for prescribing opioids for chronic pain
         <em>
         </em>
         recommends risk screening measures be used as a routine opioid prescribing practice. We also consider risk screening when prescribing other sedating controlled substances. Screening measures include review of the applicable prescription drug monitoring program (PDMP) database [
         <a href="#rid100">
          100
         </a>
         ], urine drug testing before and during opioid therapy [
         <a href="#rid101">
          101
         </a>
         ], and patient assessment for risks of overdose and opioid use disorder (including abuse and dependence) [
         <a href="#rid102">
          102,103
         </a>
         ].
        </p>
        <p>
         For patients who use or may use opioids, we use one of several available questionnaires to assess substance use disorder, such as the brief
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fcde.drugabuse.gov%2Fsites%2Fnida_cde%2Ffiles%2FTAPS%2520Tool%2520Parts%2520I%2520and%2520II%2520V2.pdf&amp;token=euoQ%2FjXMXY7wyx6OQK2Kx6JR2fOgSvr1IupnoQCO3pr%2BV4V7dB%2B4Vg76LQuMHf8%2FuXsRpWjfeUQzXUQuB1XUMxAAVkuBkZqEazwhd3uMvgJMv8wY51uqC%2FWVG2j0mV4U&amp;TOPIC_ID=116196" target="_blank">
          4-item TAPS-1
         </a>
         , the Opioid Risk Tool (ORT) [
         <a href="#rid104">
          104
         </a>
         ], Current Opioid Misuse Screen (COMM)  (
         <a class="graphic graphic_table graphicRef108385" href="/z/d/graphic/108385.html" rel="external">
          table 14
         </a>
         and
         <a class="graphic graphic_form graphicRef108922" href="/z/d/graphic/108922.html" rel="external">
          form 3
         </a>
         ), Screener and Opioid Assessment for Patients with Pain (SOAPP)  (
         <a class="graphic graphic_table graphicRef109027" href="/z/d/graphic/109027.html" rel="external">
          table 15
         </a>
         and
         <a class="graphic graphic_form graphicRef111248" href="/z/d/graphic/111248.html" rel="external">
          form 4
         </a>
         ), or CAGE-AID. TAPS-1 has been validated in primary care as a triage tool [
         <a href="#rid105">
          105
         </a>
         ]. None of the other instruments are well validated, so choice among them will be based on patient characteristics and provider preference  (
         <a class="graphic graphic_table graphicRef126443" href="/z/d/graphic/126443.html" rel="external">
          table 8
         </a>
         ).
        </p>
        <p>
         Risk assessment prior to opioid prescription and during opioid therapy, including medical issues (eg, sleep apnea, chronic obstructive pulmonary disease [COPD]), misuse screening tools, prescription drug monitoring databases, and urine drug screening, are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/93598.html" rel="external">
          "Use of opioids in the management of chronic non-cancer pain"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/118689.html" rel="external">
          "Urine drug testing for patients with chronic pain"
         </a>
         .)
        </p>
        <p>
         The CDC checklist, which includes risk prevention and assessment, is a useful tool when prescribing opioids for patients with chronic pain  (
         <a class="graphic graphic_table graphicRef120017" href="/z/d/graphic/120017.html" rel="external">
          table 16
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H2724777864">
         <span class="h1">
          REFERRAL TO A PAIN SPECIALIST
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients who may benefit from referral to an appropriate pain specialist fall into two broad overlapping groups.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients for whom interventional pain treatment may be appropriate
         </strong>
         – These patients often have these characteristics:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Localized pain with anatomic correlates (imaging, physical exam)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain not responsive to initial conservative care (ie, treatment that is potentially of equal or more benefit and less risk)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Distress and mood reasonably well controlled
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Desire to avoid surgery
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Appropriate expectations
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with complex difficult to treat pain
         </strong>
         – Reasonable criteria for referral to a pain specialist or multidisciplinary pain center include the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent pain that significantly impacts function, quality of life, anxiety, and/or depression that has not responded to management by the treating primary or specialty care provider.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent pain that cannot be explained and requires treatment.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain that may be appropriate for interventional treatment.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         High-risk or complex pain-related pharmacology or polypharmacy (high dose opioids, sedatives, multiple agents).
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent neuropathic pain that has not responded to first-line treatments.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Uncertainty regarding diagnosis or treatment for resistant nociplastic (widespread) pain.
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Need for multidimensional care (medical management, rehabilitation, mental health treatment).
        </p>
        <p>
        </p>
        <p>
         In our practice many patients referred for interventional treatments have the best outcomes when also engaged in multidisciplinary care. Similarly, patients initially treated with multidisciplinary care may ultimately benefit from interventional therapy.
        </p>
        <p class="headingAnchor" id="H623352998">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118305.html" rel="external">
          "Society guideline links: Chronic pain management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1050043015">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Types and cause of pain
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic pain can be classified as nociceptive, neuropathic, and/or nociplastic and the distinction between these types of pain has implications for the plan for treatment  (
         <a class="graphic graphic_table graphicRef126428" href="/z/d/graphic/126428.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Definition of pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Nociceptive pain is caused by stimuli that threaten or result from bodily tissue damage. (See
         <a class="local">
          'Nociceptive pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Neuropathic pain consists of a central or peripheral disorder of pain modulation, as a result of a maladaptive response to damage or pathology of the nervous system. (See
         <a class="local">
          'Neuropathic pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Nociplastic pain (also called centralized pain) results from altered pain sensory processing and impaired central pain modulation. (See
         <a class="local">
          'Nociplastic pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain is experienced in developmental, social, and emotional contexts  (
         <a class="graphic graphic_table graphicRef129909" href="/z/d/graphic/129909.html" rel="external">
          table 2
         </a>
         ). Thus, evaluation of the patient with chronic pain requires a search for a biomedical cause, psychologic and social evaluation, and assessment of physical function and sleep  (
         <a class="graphic graphic_table graphicRef126456" href="/z/d/graphic/126456.html" rel="external">
          table 7
         </a>
         ). (See
         <a class="local">
          'Chronic pain in context'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pain assessment
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pain assessment informs the choice of therapy and should be used to monitor the effect of therapy. Every effort should be made to determine the cause of the pain and whether the pain is neuropathic, nociceptive, or both. (See
         <a class="local">
          'Pain characteristics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The pain assessment should include the history of the pain, location and characteristics of the pain, evaluation of severity and impact, and a pain focused physical examination. At each visit, we assess patients with screening tools for pain characteristics, pain intensity and impact, and mood, and ask about initiation and maintenance of sleep  (
         <a class="graphic graphic_table graphicRef126456" href="/z/d/graphic/126456.html" rel="external">
          table 7
         </a>
         ). (See
         <a class="local">
          'Pain assessment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When diagnosis remains uncertain, we perform a more detailed evaluation for neuropathic pain and screen for nociplastic pain using the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.physiotutors.com%2Fquestionnaires%2Fcentral-sensitization-inventory-csi%2F&amp;token=x44j3owCE8bgzsF65rcOxODCiX%2FFdmlZ6KwyjDZXUw%2BY7zahvcH47iIKwCI93h3G0343EoXJ52IGKNhgiHCU93n8ft6gADJHBMV4DggL1W4%3D&amp;TOPIC_ID=116196" target="_blank">
          Central Sensitization Inventory
         </a>
         or other widespread pain assessment tools. (See
         <a class="local">
          'Pain characteristics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Screening
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients who have evidence of distressed mood on initial screening, we screen further for anxiety, depression, and posttraumatic stress  (
         <a class="graphic graphic_table graphicRef126456" href="/z/d/graphic/126456.html" rel="external">
          table 7
         </a>
         and
         <a class="graphic graphic_table graphicRef126443" href="/z/d/graphic/126443.html" rel="external">
          table 8
         </a>
         ). (See
         <a class="local">
          'Pain severity and impact'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients who use opioids or for whom opioids are considered, we screen for risk of opioid misuse or opioid use disorder with a screening tool  (
         <a class="graphic graphic_table graphicRef126443" href="/z/d/graphic/126443.html" rel="external">
          table 8
         </a>
         ). Prior to prescribing opioids and other potentially sedating drugs, we check the prescription drug monitoring program (PDMP) database and perform a urine drug test  (
         <a class="graphic graphic_table graphicRef120017" href="/z/d/graphic/120017.html" rel="external">
          table 16
         </a>
         ). (See
         <a class="local">
          'Risk screening'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic studies
         </strong>
         – Imaging studies, diagnostic nerve blocks, and electrodiagnostic testing may be helpful for diagnosis of conditions that may cause chronic pain. (See
         <a class="local">
          'Diagnostic studies for the evaluation of pain'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Referral
         </strong>
         – Patients with complex, difficult to treat pain should be referred to a pain specialist or multidisciplinary pain center for evaluation and treatment. (See
         <a class="local">
          'Referral to a pain specialist'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Tumin D, Drees D, Miller R, et al. Health Care Utilization and Costs Associated With Pediatric Chronic Pain. J Pain 2018; 19:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rikard SM, Strahan AE, Schmit KM, Guy GP Jr. Chronic Pain Among Adults - United States, 2019-2021. MMWR Morb Mortal Wkly Rep 2023; 72:379.
          </a>
         </li>
         <li class="breakAll">
          Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research, The National Academies Press, Washington, DC 2011.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johannes CB, Le TK, Zhou X, et al. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain 2010; 11:1230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain 2022; 163:e328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers 2017; 3:17002.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouhassira D, Lantéri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008; 136:380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azevedo LF, Costa-Pereira A, Mendonça L, et al. The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal. Eur J Health Econ 2016; 17:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montgomery W, Sato M, Nagasaka Y, Vietri J. The economic and humanistic costs of chronic lower back pain in Japan. Clinicoecon Outcomes Res 2017; 9:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dureja GP, Jain PN, Shetty N, et al. Prevalence of chronic pain, impact on daily life, and treatment practices in India. Pain Pract 2014; 14:E51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groenewald CB, Essner BS, Wright D, et al. The economic costs of chronic pain among a cohort of treatment-seeking adolescents in the United States. J Pain 2014; 15:925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain 2020; 161:1976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kucyi A, Davis KD. The dynamic pain connectome. Trends Neurosci 2015; 38:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mason KJ, O'Neill TW, Lunt M, et al. Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain. Scand J Pain 2018; 18:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Generaal E, Vogelzangs N, Macfarlane GJ, et al. Biological Stress Systems, Adverse Life Events, and the Improvement of Chronic Multisite Musculoskeletal Pain Across a 6-Year Follow-Up. J Pain 2017; 18:155.
          </a>
         </li>
         <li class="breakAll">
          https://www.nice.org.uk/guidance/ng193.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019; 160:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol 2019; 33:101415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kucyi A, Davis KD. The Neural Code for Pain: From Single-Cell Electrophysiology to the Dynamic Pain Connectome. Neuroscientist 2017; 23:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olesen AE, Andresen T, Staahl C, Drewes AM. Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs. Pharmacol Rev 2012; 64:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arendt-Nielsen L, Yarnitsky D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J Pain 2009; 10:556.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meacham K, Shepherd A, Mohapatra DP, Haroutounian S. Neuropathic Pain: Central vs. Peripheral Mechanisms. Curr Pain Headache Rep 2017; 21:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jia Y, Shen Z, Lin G, et al. Lumbar Spinal Cord Activity and Blood Biochemical Changes in Individuals With Diabetic Peripheral Neuropathy During Electrical Stimulation. Front Neurol 2019; 10:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subedi B, Grossberg GT. Phantom limb pain: mechanisms and treatment approaches. Pain Res Treat 2011; 2011:864605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Widerström-Noga E. Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management. Drugs 2017; 77:967.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tampin B, Broe RE, Seow LL, et al. Field testing of the revised neuropathic pain grading system in a cohort of patients with neck and upper limb pain. Scand J Pain 2019; 19:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain 2016; 157:1382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 2016; 338:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mease PJ, Hanna S, Frakes EP, Altman RD. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol 2011; 38:1546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lluch E, Torres R, Nijs J, Van Oosterwijck J. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain 2014; 18:1367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cashman MD, Martin DK, Dhillon S, Puli SR. Irritable Bowel Syndrome: A Clinical Review. Curr Rheumatol Rev 2016; 12:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dimcevski G, Sami SA, Funch-Jensen P, et al. Pain in chronic pancreatitis: the role of reorganization in the central nervous system. Gastroenterology 2007; 132:1546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steege JF, Siedhoff MT. Chronic pelvic pain. Obstet Gynecol 2014; 124:616.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lai HH, Gardner V, Ness TJ, Gereau RW 4th. Segmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: evidence of central sensitization. J Urol 2014; 191:1294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll CP, Lanzkron S, Haywood C Jr, et al. Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease. Am J Prev Med 2016; 51:S69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ossipov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain. Curr Opin Support Palliat Care 2014; 8:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davis KD, Seminowicz DA. Insights for Clinicians From Brain Imaging Studies of Pain. Clin J Pain 2017; 33:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walitt B, Ceko M, Gracely JL, Gracely RH. Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature. Curr Rheumatol Rev 2016; 12:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lacagnina MJ, Watkins LR, Grace PM. Toll-like receptors and their role in persistent pain. Pharmacol Ther 2018; 184:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddi D, Curran N. Chronic pain after surgery: pathophysiology, risk factors and prevention. Postgrad Med J 2014; 90:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng JC, Anzolin A, Berry M, et al. Dynamic Functional Brain Connectivity Underlying Temporal Summation of Pain in Fibromyalgia. Arthritis Rheumatol 2022; 74:700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peng L, Ren L, Qin P, et al. Continuous Femoral Nerve Block versus Intravenous Patient Controlled Analgesia for Knee Mobility and Long-Term Pain in Patients Receiving Total Knee Replacement: A Randomized Controlled Trial. Evid Based Complement Alternat Med 2014; 2014:569107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsia HL, Takemoto S, van de Ven T, et al. Acute Pain Is Associated With Chronic Opioid Use After Total Knee Arthroplasty. Reg Anesth Pain Med 2018; 43:705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langford DJ, Theodore BR, Balsiger D, et al. Number and Type of Post-Traumatic Stress Disorder Symptom Domains Are Associated With Patient-Reported Outcomes in Patients With Chronic Pain. J Pain 2018; 19:506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Phifer J, Skelton K, Weiss T, et al. Pain symptomatology and pain medication use in civilian PTSD. Pain 2011; 152:2233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martel MO, Shir Y, Ware MA. Substance-related disorders: A review of prevalence and correlates among patients with chronic pain. Prog Neuropsychopharmacol Biol Psychiatry 2018; 87:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clauw DJ, Häuser W, Cohen SP, Fitzcharles MA. Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain 2020; 161:1694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anaya JM, Rojas M, Salinas ML, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev 2021; 20:102947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shanthanna H, Nelson AM, Kissoon N, Narouze S. The COVID-19 pandemic and its consequences for chronic pain: a narrative review. Anaesthesia 2022; 77:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turk DC, Okifuji A. Psychological factors in chronic pain: evolution and revolution. J Consult Clin Psychol 2002; 70:678.
          </a>
         </li>
         <li class="breakAll">
          International Association for the Study of Pain. IASP Taxonomy. https://www.iasp-pain.org/Taxonomy (Accessed on January 10, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Badr H, Shen MJ. Pain catastrophizing, pain intensity, and dyadic adjustment influence patient and partner depression in metastatic breast cancer. Clin J Pain 2014; 30:923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walco GA, Krane EJ, Schmader KE, Weiner DK. Applying a Lifespan Developmental Perspective to Chronic Pain: Pediatrics to Geriatrics. J Pain 2016; 17:T108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen RD, Langius-Eklöf A, Nakstad B, et al. The measurement properties of pediatric observational pain scales: A systematic review of reviews. Int J Nurs Stud 2017; 73:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim YS, Park JM, Moon YS, Han SH. Assessment of pain in the elderly: A literature review. Natl Med J India 2017; 30:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy UM, Davis JM, Ren Z, et al. Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstet Gynecol 2017; 130:10.
          </a>
         </li>
         <li class="breakAll">
          Interagency Guideline on Prescribing Opioids for Pain. Available at: http://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.pdf (Accessed on January 27, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scott JG, Scott RG, Miller WL, et al. Healing relationships and the existential philosophy of Martin Buber. Philos Ethics Humanit Med 2009; 4:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belcher AM, Ferré S, Martinez PE, Colloca L. Role of placebo effects in pain and neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2018; 87:298.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rose AR, Catcheside PG, McEvoy RD, et al. Sleep disordered breathing and chronic respiratory failure in patients with chronic pain on long term opioid therapy. J Clin Sleep Med 2014; 10:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Br J Clin Pharmacol 2016; 81:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spindelegger CJ, Papageorgiou K, Grohmann R, et al. Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. Int J Neuropsychopharmacol 2014; 18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc 2015; 90:680.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siqveland J, Ruud T, Hauff E. Post-traumatic stress disorder moderates the relationship between trauma exposure and chronic pain. Eur J Psychotraumatol 2017; 8:1375337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan MD, Ballantyne JC. What are we treating with long-term opioid therapy? Arch Intern Med 2012; 172:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pryzbylkowski P, Ashburn MA. The Pain Medical Home: A Patient-Centered Medical Home Model of Care for Patients with Chronic Pain. Anesthesiol Clin 2015; 33:785.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Annagür BB, Uguz F, Apiliogullari S, et al. Psychiatric disorders and association with quality of sleep and quality of life in patients with chronic pain: a SCID-based study. Pain Med 2014; 15:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 2003; 106:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fishbain DA, Cole B, Lewis JE, Gao J. Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review. Pain Med 2014; 15:1522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang NK, Crane C. Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links. Psychol Med 2006; 36:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petrosky E, Harpaz R, Fowler KA, et al. Chronic Pain Among Suicide Decedents, 2003 to 2014: Findings From the National Violent Death Reporting System. Ann Intern Med 2018; 169:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith K, Mattick RP, Bruno R, et al. Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain. J Affect Disord 2015; 184:72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wideman TH, Edwards RR, Walton DM, et al. The Multimodal Assessment Model of Pain: A Novel Framework for Further Integrating the Subjective Pain Experience Within Research and Practice. Clin J Pain 2019; 35:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997; 48:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen MP, Dworkin RH, Gammaitoni AR, et al. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 2005; 6:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayer TG, Neblett R, Cohen H, et al. The development and psychometric validation of the central sensitization inventory. Pain Pract 2012; 12:276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neblett R, Cohen H, Choi Y, et al. The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample. J Pain 2013; 14:438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neblett R, Hartzell MM, Mayer TG, et al. Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory. Pain Pract 2017; 17:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neblett R, Hartzell MM, Cohen H, et al. Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain 2015; 31:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan MD, Ballantyne JC. Must we reduce pain intensity to treat chronic pain? Pain 2016; 157:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep 2016; 65:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krebs EE, Lorenz KA, Bair MJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med 2009; 24:733.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009; 50:613.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prins A, Bovin MJ, Smolenski DJ, et al. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample. J Gen Intern Med 2016; 31:1206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spoont MR, Williams JW Jr, Kehle-Forbes S, et al. Does This Patient Have Posttraumatic Stress Disorder?: Rational Clinical Examination Systematic Review. JAMA 2015; 314:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: Development and validation. Psyc Assessment 1995; 7:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walton DM, Mehta S, Seo W, MacDermid JC. Creation and validation of the 4-item BriefPCS-chronic through methodological triangulation. Health Qual Life Outcomes 2020; 18:124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polomano RC, Galloway KT, Kent ML, et al. Psychometric Testing of the Defense and Veterans Pain Rating Scale (DVPRS): A New Pain Scale for Military Population. Pain Med 2016; 17:1505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain 2013; 14:1539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaughnessy AF. CBT Effective for Chronic Insomnia. Am Fam Physician 2016; 93:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arendt-Nielsen L. Pain sensitisation in osteoarthritis. Clin Exp Rheumatol 2017; 35 Suppl 107:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woolf CJ. Central sensitization: Implications for the diagnosis and treatment of pain. Pain 2011; 152:S2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen BB, Hansen P, Carrino JA, et al. Imaging in mechanical back pain: Anything new? Best Pract Res Clin Rheumatol 2016; 30:766.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCullough BJ, Johnson GR, Martin BI, Jarvik JG. Lumbar MR imaging and reporting epidemiology: do epidemiologic data in reports affect clinical management? Radiology 2012; 262:941.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarvik JG, Comstock BA, James KT, et al. Lumbar Imaging With Reporting Of Epidemiology (LIRE)--Protocol for a pragmatic cluster randomized trial. Contemp Clin Trials 2015; 45:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rajasekaran S, Dilip Chand Raja S, Pushpa BT, et al. The catastrophization effects of an MRI report on the patient and surgeon and the benefits of 'clinical reporting': results from an RCT and blinded trials. Eur Spine J 2021; 30:2069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patrick SW, Fry CE, Jones TF, Buntin MB. Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates. Health Aff (Millwood) 2016; 35:1324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Argoff CE, Alford DP, Fudin J, et al. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations. Pain Med 2018; 19:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dowell D, Ragan KR, Jones CM, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep 2022; 71:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheatle MD, Compton PA, Dhingra L, et al. Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Nonmalignant Pain. J Pain 2019; 20:842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gryczynski J, McNeely J, Wu LT, et al. Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. J Gen Intern Med 2017; 32:990.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 116196 Version 16.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29608973" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Health Care Utilization and Costs Associated With Pediatric Chronic Pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37053114" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Chronic Pain Among Adults - United States, 2019-2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37053114" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Chronic Pain Among Adults - United States, 2019-2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20797916" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The prevalence of chronic pain in United States adults: results of an Internet-based survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33990113" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Prevalence of chronic pain among adults in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28205574" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Neuropathic pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17888574" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Prevalence of chronic pain with neuropathic characteristics in the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25416319" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28694702" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The economic and humanistic costs of chronic lower back pain in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24304963" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Prevalence of chronic pain, impact on daily life, and treatment practices in India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28919117" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24953887" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The economic costs of chronic pain among a cohort of treatment-seeking adolescents in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32694387" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25541287" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The dynamic pain connectome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29794289" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Psychosocial factors partially mediate the relationship between mechanical hyperalgesia and self-reported pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27825856" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Biological Stress Systems, Adverse Life Events, and the Improvement of Chronic Multisite Musculoskeletal Pain Across a 6-Year Follow-Up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27825856" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Biological Stress Systems, Adverse Life Events, and the Improvement of Chronic Multisite Musculoskeletal Pain Across a 6-Year Follow-Up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30586067" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31703792" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : New concepts of pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27660241" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The Neural Code for Pain: From Single-Cell Electrophysiology to the Dynamic Pain Connectome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22722894" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19380256" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28432601" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Neuropathic Pain: Central vs. Peripheral Mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30936849" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Lumbar Spinal Cord Activity and Blood Biochemical Changes in Individuals With Diabetic Peripheral Neuropathy During Electrical Stimulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22110933" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Phantom limb pain: mechanisms and treatment approaches.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28451808" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30901318" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Field testing of the revised neuropathic pain grading system in a cohort of patients with neck and upper limb pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26835783" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Do we need a third mechanistic descriptor for chronic pain states?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27291641" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Neurobiology of fibromyalgia and chronic widespread pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21632678" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24700605" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26717952" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Irritable Bowel Syndrome: A Clinical Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17408654" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Pain in chronic pancreatitis: the role of reorganization in the central nervous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25162265" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Chronic pelvic pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24316091" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Segmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: evidence of central sensitization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27320469" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24752199" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Descending pain modulation and chronification of pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27648589" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Insights for Clinicians From Brain Imaging Studies of Pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26717948" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28987324" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Toll-like receptors and their role in persistent pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24572639" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Chronic pain after surgery: pathophysiology, risk factors and prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34725971" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Dynamic Functional Brain Connectivity Underlying Temporal Summation of Pain in Fibromyalgia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25254055" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Continuous Femoral Nerve Block versus Intravenous Patient Controlled Analgesia for Knee Mobility and Long-Term Pain in Patients Receiving Total Knee Replacement: A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29975257" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Acute Pain Is Associated With Chronic Opioid Use After Total Knee Arthroplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29307748" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Number and Type of Post-Traumatic Stress Disorder Symptom Domains Are Associated With Patient-Reported Outcomes in Patients With Chronic Pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21665366" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Pain symptomatology and pain medication use in civilian PTSD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28669582" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Substance-related disorders: A review of prevalence and correlates among patients with chronic pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32701829" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Considering the potential for an increase in chronic pain after the COVID-19 pandemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34509649" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Post-COVID syndrome. A case series and comprehensive review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35848380" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The COVID-19 pandemic and its consequences for chronic pain: a narrative review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12090376" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Psychological factors in chronic pain: evolution and revolution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12090376" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Psychological factors in chronic pain: evolution and revolution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24402001" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Pain catastrophizing, pain intensity, and dyadic adjustment influence patient and partner depression in metastatic breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27586828" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Applying a Lifespan Developmental Perspective to Chronic Pain: Pediatrics to Geriatrics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28558342" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The measurement properties of pediatric observational pain scales: A systematic review of reviews.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29162753" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Assessment of pain in the elderly: A literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28594753" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28594753" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19678950" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Healing relationships and the existential philosophy of Martin Buber.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28595945" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Role of placebo effects in pain and neuropsychiatric disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25126029" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Sleep disordered breathing and chronic respiratory failure in patients with chronic pain on long term opioid therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26337922" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25522416" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25939940" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Fibromyalgia and related conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29038680" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Post-traumatic stress disorder moderates the relationship between trauma exposure and chronic pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22412109" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : What are we treating with long-term opioid therapy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26610630" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : The Pain Medical Home: A Patient-Centered Medical Home Model of Care for Patients with Chronic Pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24612225" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Psychiatric disorders and association with quality of sleep and quality of life in patients with chronic pain: a SCID-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14581119" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25139618" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16420727" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30208405" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Chronic Pain Among Suicide Decedents, 2003 to 2014: Findings From the National Violent Death Reporting System.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26072316" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30444733" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : The Multimodal Assessment Model of Pain: A Novel Framework for Further Integrating the Subjective Pain Experience Within Research and Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9040716" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15694876" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11323136" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15733628" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21951710" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : The development and psychometric validation of the central sensitization inventory.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23490634" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26989894" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Establishing Clinically Relevant Severity Levels for the Central Sensitization Inventory.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24806467" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26307855" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Must we reduce pain intensity to treat chronic pain?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26987082" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19418100" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19996233" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : An ultra-brief screening scale for anxiety and depression: the PHQ-4.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27170304" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26241601" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Does This Patient Have Posttraumatic Stress Disorder?: Rational Clinical Examination Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : The pain catastrophizing scale: Development and validation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32381020" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Creation and validation of the 4-item BriefPCS-chronic through methodological triangulation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27272528" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Psychometric Testing of the Defense and Veterans Pain Rating Scale (DVPRS): A New Pain Scale for Military Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24290442" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : The association of sleep and pain: an update and a path forward.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26760845" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : CBT Effective for Chronic Insomnia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28967356" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Pain sensitisation in osteoarthritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20961685" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Central sensitization: Implications for the diagnosis and treatment of pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27931967" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Imaging in mechanical back pain: Anything new?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22357893" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Lumbar MR imaging and reporting epidemiology: do epidemiologic data in reports affect clinical management?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26493088" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Lumbar Imaging With Reporting Of Epidemiology (LIRE)--Protocol for a pragmatic cluster randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33748882" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : The catastrophization effects of an MRI report on the patient and surgeon and the benefits of 'clinical reporting': results from an RCT and blinded trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27335101" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29206984" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19187889" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36327391" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30690168" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Nonmalignant Pain.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28550609" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
